e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Pulmonary hypertension in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Laura Price (London, United Kingdom), Laura Price, Aleksander Kempny, Kostantinos Dimopoulos, Raphael Alonso, Lisa Parfitt, Carl Harries, Martin Carby, Andre Simon, Athol Wells, John Wort, Anna Reed
Source:
International Congress 2015 – Pulmonary hypertension in lung disease
Session:
Pulmonary hypertension in lung disease
Session type:
Thematic Poster Session
Number:
3765
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Laura Price (London, United Kingdom), Laura Price, Aleksander Kempny, Kostantinos Dimopoulos, Raphael Alonso, Lisa Parfitt, Carl Harries, Martin Carby, Andre Simon, Athol Wells, John Wort, Anna Reed. Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?. Eur Respir J 2015; 46: Suppl. 59, 3765
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Pulmonary hypertension in patients with interstitial lung disease
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007
Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013
Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung
Source: Eur Respir J 2003; 21: 192-194
Year: 2003
Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease
Source: Eur Respir J 2009; 34: 1348-1356
Year: 2009
Pulmonary hypertension due to lung disease
Source: International Congress 2017 – Russian Programme 2017
Year: 2017
Prognosis in patients with primary pulmonary hypertension awaiting lung transplantion
Source: Eur Respir J 2001; 18: Suppl. 33, 297s
Year: 2001
Efficacy of pulmonary rehabilitation in patients with interstitial lung disease
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Biomarkers for pulmonary hypertension in interstitial lung disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Pulmonary hypertension in interstitial lung diseases
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Pulmonary hypertension in interstitial lung disease: Non-invasive assessment for detection and prognosis
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 387s
Year: 2007
Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Inhaled treprostinil therapy in patients with pulmonary hypertension and parenchymal lung disease
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011
Pulmonary hypertension in interstitial lung disease
Source: Eur Respir J 2008; 31: 1357-1367
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept